Citigroup Maintains Buy on DexCom, Lowers Price Target to $79

Benzinga Newsdesk www.benzinga.com Negative 69.9%

Neg 69.9% Neu 0% Pos 0%

Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $84 to $79.

Comments

No comments yet. Be the first!